The upward momentum of EUR/USD persists, consistently tracking the growing selling pressure on the US Dollar, which continues to grapple with issues related to trade, the Fed's independence, and the ...

Shield’s FDA-approved blood test drives cancer screening growth, pricing power, and cash-flow upside. Click for this GH ...

The Nifty 50 forecasts for 2026 will be hinged on RBI policy, domestic v foreign flows and the earnings docket of its listed ...

A few names have received three or more positive stock ratings since the end of 2025, suggesting the Street is becoming ...

The Vanguard S&P 500 ETF (VOO) has moved sideways in the past few weeks and is hovering near its all-time high as the ...

Palantir remains a bullish conviction supported by strong commercial growth and robust free cash flow trends. Click here to ...

Gold continues to power higher on Monday, despite the fact that holiday trading will have shortened hours and thinner trading ...

Gold's blistering run in 2025 has left investors fixated on what comes next, and Wall Street has responded with some of its ...

Bitcoin looks ready to continue its recovery, but an "inflection point" at $98,000 must be flipped into new support.

In the meantime, the Relative Strength Index (RSI) has crossed below the 14-day moving average, which is also a bearish ...

Market reclaims foundation for a recovery, especially after multiple assets reported enormous exchange outflows that create ...

The world’s largest cryptocurrency rose more than 4.5% on Tuesday, closing above a key resistance zone as investors responded ...